ID   TCPG_HUMAN              Reviewed;         545 AA.
AC   P49368; A6NE14; Q5SZY1; Q9BR64;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 4.
DT   28-JAN-2026, entry version 235.
DE   RecName: Full=T-complex protein 1 subunit gamma;
DE            Short=TCP-1-gamma;
DE            EC=3.6.1.- {ECO:0000305|PubMed:35449234, ECO:0000305|PubMed:36493755, ECO:0000305|PubMed:37193829};
DE   AltName: Full=CCT-gamma;
DE   AltName: Full=Chaperonin containing T-complex polypeptide 1 subunit 3;
DE   AltName: Full=hTRiC5;
GN   Name=CCT3; Synonyms=CCTG, TRIC5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-15; 32-38; 49-85; 129-138; 182-191; 238-248; 295-306;
RP   382-389; 428-449 AND 508-528, ACETYLATION AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Hepatoma;
RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-545.
RC   TISSUE=Kidney;
RX   PubMed=8573069; DOI=10.1042/bj3130381;
RA   Walkley N.A., Demaine A.G., Malik A.N.;
RT   "Cloning, structure and mRNA expression of human Cctg, which encodes the
RT   chaperonin subunit CCT gamma.";
RL   Biochem. J. 313:381-389(1996).
RN   [7]
RP   PROTEIN SEQUENCE OF 204-216; 331-353 AND 508-518, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 345-544.
RX   PubMed=8001976; DOI=10.1006/geno.1994.1438;
RA   Sevigny G., Joly E., Bibor-Hardy V., Lemieux N.;
RT   "Assignment of the human homologue of the mTRiC-P5 gene (TRIC5) to band
RT   1q23 by fluorescence in situ hybridization.";
RL   Genomics 22:634-636(1994).
RN   [9]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.m309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-222, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   FUNCTION, AND IDENTIFICATION IN THE CHAPERONIN-CONTAINING T-COMPLEX.
RX   PubMed=20080638; DOI=10.1073/pnas.0910268107;
RA   Seo S., Baye L.M., Schulz N.P., Beck J.S., Zhang Q., Slusarski D.C.,
RA   Sheffield V.C.;
RT   "BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and
RT   mediate BBSome assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:1488-1493(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   FUNCTION, AND IDENTIFICATION IN THE CHAPERONIN-CONTAINING T-COMPLEX.
RX   PubMed=25467444; DOI=10.1016/j.cell.2014.10.059;
RA   Freund A., Zhong F.L., Venteicher A.S., Meng Z., Veenstra T.D., Frydman J.,
RA   Artandi S.E.;
RT   "Proteostatic control of telomerase function through TRiC-mediated folding
RT   of TCAB1.";
RL   Cell 159:1389-1403(2014).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-243; TYR-247;
RP   SER-252; THR-430 AND THR-459, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-381, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-15; LYS-248 AND LYS-249, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   INTERACTION WITH DLEC1.
RX   PubMed=33144677; DOI=10.1038/s41598-020-75957-y;
RA   Okitsu Y., Nagano M., Yamagata T., Ito C., Toshimori K., Dohra H.,
RA   Fujii W., Yogo K.;
RT   "Dlec1 is required for spermatogenesis and male fertility in mice.";
RL   Sci. Rep. 10:18883-18883(2020).
RN   [24] {ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7WU7}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS) IN COMPLEX WITH TUBULIN,
RP   FUNCTION, SUBUNIT, ADP AND MG(2+) BINDING SITES, AND CATALYTIC ACTIVITY.
RX   PubMed=36493755; DOI=10.1016/j.cell.2022.11.014;
RA   Gestaut D., Zhao Y., Park J., Ma B., Leitner A., Collier M., Pintilie G.,
RA   Roh S.H., Chiu W., Frydman J.;
RT   "Structural visualization of the tubulin folding pathway directed by human
RT   chaperonin TRiC/CCT.";
RL   Cell 185:4770-4787.e20(2022).
RN   [25] {ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7NVO}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.50 ANGSTROMS) IN COMPLEX WITH TUBULIN
RP   AND IN COMPLEX WITH ACTIN, FUNCTION, SUBUNIT, ADP AND MG(2+) BINDING SITES,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=35449234; DOI=10.1038/s41594-022-00755-1;
RA   Kelly J.J., Tranter D., Pardon E., Chi G., Kramer H., Happonen L.,
RA   Knee K.M., Janz J.M., Steyaert J., Bulawa C., Paavilainen V.O.,
RA   Huiskonen J.T., Yue W.W.;
RT   "Snapshots of actin and tubulin folding inside the TRiC chaperonin.";
RL   Nat. Struct. Mol. Biol. 29:420-429(2022).
RN   [26] {ECO:0007744|PDB:7WZ3, ECO:0007744|PDB:7X0A, ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V, ECO:0007744|PDB:7X3J, ECO:0007744|PDB:7X3U, ECO:0007744|PDB:7X6Q, ECO:0007744|PDB:7X7Y}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS) IN COMPLEX WITH TUBULIN,
RP   FUNCTION, SUBUNIT, ATP; ADP AND MG(2+) BINDING SITES, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=37193829; DOI=10.1038/s42003-023-04915-x;
RA   Liu C., Jin M., Wang S., Han W., Zhao Q., Wang Y., Xu C., Diao L., Yin Y.,
RA   Peng C., Peng C., Bao L., Wang Y., Cong Y.;
RT   "Pathway and mechanism of tubulin folding mediated by TRiC/CCT along its
RT   ATPase cycle revealed using cryo-EM.";
RL   Commun. Biol. 6:531-531(2023).
RN   [27]
RP   VARIANTS NEDSVH ARG-12 AND 518-ARG--GLU-545 DEL, CHARACTERIZATION OF
RP   VARIANTS NEDSVH ARG-12 AND 518-ARG--GLU-545 DEL, AND INVOLVEMENT IN NEDSVH.
RX   PubMed=39480921; DOI=10.1126/science.adp8721;
RA   Kraft F., Rodriguez-Aliaga P., Yuan W., Franken L., Zajt K., Hasan D.,
RA   Lee T.T., Flex E., Hentschel A., Innes A.M., Zheng B., Julia Suh D.S.,
RA   Knopp C., Lausberg E., Krause J., Zhang X., Trapane P., Carroll R.,
RA   McClatchey M., Fry A.E., Wang L., Giesselmann S., Hoang H., Baldridge D.,
RA   Silverman G.A., Radio F.C., Bertini E., Ciolfi A., Blood K.A.,
RA   de Sainte Agathe J.M., Charles P., Bergant G., Cuturilo G., Peterlin B.,
RA   Diderich K., Streff H., Robak L., Oegema R., van Binsbergen E.,
RA   Herriges J., Saunders C.J., Maier A., Wolking S., Weber Y., Lochmueller H.,
RA   Meyer S., Aleman A., Polavarapu K., Nicolas G., Goldenberg A., Guyant L.,
RA   Pope K., Hehmeyer K.N., Monaghan K.G., Quade A., Smol T., Caumes R.,
RA   Duerinckx S., Depondt C., Van Paesschen W., Rieubland C., Poloni C.,
RA   Guipponi M., Arcioni S., Meuwissen M., Jansen A.C., Rosenblum J.,
RA   Haack T.B., Bertrand M., Gerstner L., Magg J., Riess O., Schulz J.B.,
RA   Wagner N., Wiesmann M., Weis J., Eggermann T., Begemann M., Roos A.,
RA   Haeusler M., Schedl T., Tartaglia M., Bremer J., Pak S.C., Frydman J.,
RA   Elbracht M., Kurth I.;
RT   "Brain malformations and seizures by impaired chaperonin function of
RT   TRiC.";
RL   Science 386:516-525(2024).
CC   -!- FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a
CC       molecular chaperone complex that assists the folding of actin, tubulin
CC       and other proteins upon ATP hydrolysis (PubMed:25467444,
CC       PubMed:36493755, PubMed:35449234, PubMed:37193829). The TRiC complex
CC       mediates the folding of WRAP53/TCAB1, thereby regulating telomere
CC       maintenance (PubMed:25467444). As part of the TRiC complex may play a
CC       role in the assembly of BBSome, a complex involved in ciliogenesis
CC       regulating transports vesicles to the cilia (PubMed:20080638).
CC       {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444,
CC       ECO:0000269|PubMed:35449234, ECO:0000269|PubMed:36493755,
CC       ECO:0000269|PubMed:37193829}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000305|PubMed:35449234, ECO:0000305|PubMed:36493755,
CC         ECO:0000305|PubMed:37193829};
CC   -!- SUBUNIT: Component of the chaperonin-containing T-complex (TRiC), a
CC       hexadecamer composed of two identical back-to-back stacked rings
CC       enclosing a protein folding chamber (PubMed:20080638, PubMed:25467444,
CC       PubMed:36493755, PubMed:35449234, PubMed:37193829). Each ring is made
CC       up of eight different subunits: TCP1/CCT1, CCT2, CCT3, CCT4, CCT5,
CC       CCT6A/CCT6, CCT7, CCT8 (PubMed:36493755, PubMed:35449234,
CC       PubMed:37193829). Interacts with PACRG (PubMed:14532270). Interacts
CC       with DNAAF4 (By similarity). Interacts with DLEC1 (PubMed:33144677).
CC       {ECO:0000250|UniProtKB:P80318, ECO:0000269|PubMed:14532270,
CC       ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444,
CC       ECO:0000269|PubMed:33144677, ECO:0000269|PubMed:35449234,
CC       ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829}.
CC   -!- INTERACTION:
CC       P49368; O75140-2: DEPDC5; NbExp=3; IntAct=EBI-356673, EBI-12366971;
CC       P49368; O75530: EED; NbExp=2; IntAct=EBI-356673, EBI-923794;
CC       P49368; P57678: GEMIN4; NbExp=3; IntAct=EBI-356673, EBI-356700;
CC       P49368; Q99759: MAP3K3; NbExp=2; IntAct=EBI-356673, EBI-307281;
CC       P49368; Q8TD10: MIPOL1; NbExp=6; IntAct=EBI-356673, EBI-2548751;
CC       P49368; Q13371: PDCL; NbExp=10; IntAct=EBI-356673, EBI-5772890;
CC       P49368; O15160: POLR1C; NbExp=3; IntAct=EBI-356673, EBI-1055079;
CC       P49368; P04049: RAF1; NbExp=8; IntAct=EBI-356673, EBI-365996;
CC       P49368; Q9H832: UBE2Z; NbExp=3; IntAct=EBI-356673, EBI-720977;
CC       P49368; O60232: ZNRD2; NbExp=6; IntAct=EBI-356673, EBI-741415;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49368-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49368-2; Sequence=VSP_042026;
CC   -!- DISEASE: Neurodevelopmental disorder with speech or visual impairment
CC       and brain hypomyelination (NEDSVH) [MIM:621034]: An autosomal dominant
CC       disorder characterized by global developmental delay, impaired
CC       intellectual development, poor or absent speech, and brain
CC       abnormalities including hypomyelination, cerebellar atrophy, and optic
CC       nerve atrophy. Some patients have severe visual impairment, dystonic
CC       movements, and seizures. {ECO:0000269|PubMed:39480921}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the TCP-1 chaperonin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH08019.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK293477; BAG56968.1; -; mRNA.
DR   EMBL; AL833197; CAI46192.1; -; mRNA.
DR   EMBL; AL589685; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006501; AAH06501.3; -; mRNA.
DR   EMBL; BC008019; AAH08019.1; ALT_INIT; mRNA.
DR   EMBL; X74801; CAA52808.1; -; mRNA.
DR   EMBL; U17104; AAC50068.1; -; mRNA.
DR   CCDS; CCDS1140.2; -. [P49368-1]
DR   CCDS; CCDS30888.1; -. [P49368-2]
DR   PIR; S61529; A38983.
DR   RefSeq; NP_001008800.1; NM_001008800.3. [P49368-2]
DR   RefSeq; NP_005989.3; NM_005998.4. [P49368-1]
DR   PDB; 6NR8; EM; 7.80 A; C/K=13-525.
DR   PDB; 6NR9; EM; 8.50 A; C/K=13-525.
DR   PDB; 6NRA; EM; 7.70 A; C/K=13-525.
DR   PDB; 6NRB; EM; 8.70 A; C/K=13-525.
DR   PDB; 6NRC; EM; 8.30 A; C/K=13-525.
DR   PDB; 6NRD; EM; 8.20 A; C/K=13-525.
DR   PDB; 6QB8; EM; 3.97 A; G/g=2-545.
DR   PDB; 7LUM; EM; 4.50 A; H/P=1-545.
DR   PDB; 7LUP; EM; 6.20 A; H/P=1-545.
DR   PDB; 7NVL; EM; 2.50 A; G/g=1-545.
DR   PDB; 7NVM; EM; 3.10 A; G/g=1-545.
DR   PDB; 7NVN; EM; 3.00 A; G/g=1-545.
DR   PDB; 7NVO; EM; 3.50 A; G/g=1-545.
DR   PDB; 7TRG; EM; 3.00 A; H=1-545.
DR   PDB; 7TTN; EM; 3.30 A; H=1-545.
DR   PDB; 7TTT; EM; 2.90 A; H=1-545.
DR   PDB; 7TUB; EM; 3.60 A; H=1-545.
DR   PDB; 7WU7; EM; 3.85 A; C/K=1-545.
DR   PDB; 7WZ3; EM; 4.10 A; G/g=1-545.
DR   PDB; 7X0A; EM; 3.10 A; G/g=1-545.
DR   PDB; 7X0S; EM; 3.10 A; G/N=1-545.
DR   PDB; 7X0V; EM; 3.20 A; G/N=1-545.
DR   PDB; 7X3J; EM; 4.20 A; G/g=1-545.
DR   PDB; 7X3U; EM; 3.30 A; G/g=1-545.
DR   PDB; 7X6Q; EM; 4.50 A; G/N=1-545.
DR   PDB; 7X7Y; EM; 3.80 A; G/g=1-545.
DR   PDB; 8HKI; EM; 3.10 A; G/g=1-545.
DR   PDB; 8I1U; EM; 3.24 A; C/K=1-545.
DR   PDB; 8I6J; EM; 3.82 A; C=1-545.
DR   PDB; 8I9U; EM; 3.10 A; C/K=1-545.
DR   PDB; 8IB8; EM; 4.42 A; C/K=1-545.
DR   PDB; 8SFE; EM; 3.36 A; G/g=3-530.
DR   PDB; 8SFF; EM; 3.20 A; G/g=3-530.
DR   PDB; 8SG8; EM; 3.00 A; G/g=3-530.
DR   PDB; 8SG9; EM; 2.90 A; G/g=3-530.
DR   PDB; 8SGC; EM; 2.90 A; G/g=3-530.
DR   PDB; 8SGL; EM; 2.90 A; G/g=3-530.
DR   PDB; 8SGQ; EM; 3.70 A; G/g=3-530.
DR   PDB; 8SH9; EM; 2.70 A; G/g=3-530.
DR   PDB; 8SHA; EM; 3.00 A; G/g=3-530.
DR   PDB; 8SHD; EM; 2.90 A; G/g=3-530.
DR   PDB; 8SHE; EM; 2.80 A; G/g=3-530.
DR   PDB; 8SHF; EM; 3.00 A; G/g=3-530.
DR   PDB; 8SHG; EM; 2.80 A; G/g=3-530.
DR   PDB; 8SHL; EM; 3.00 A; G/g=3-530.
DR   PDB; 8SHN; EM; 2.80 A; G/g=3-530.
DR   PDB; 8SHO; EM; 3.00 A; G/g=3-530.
DR   PDB; 8SHP; EM; 3.00 A; G/g=3-530.
DR   PDB; 8SHQ; EM; 2.90 A; G/g=3-530.
DR   PDB; 8SHT; EM; 3.00 A; G/g=3-530.
DR   PDBsum; 6NR8; -.
DR   PDBsum; 6NR9; -.
DR   PDBsum; 6NRA; -.
DR   PDBsum; 6NRB; -.
DR   PDBsum; 6NRC; -.
DR   PDBsum; 6NRD; -.
DR   PDBsum; 6QB8; -.
DR   PDBsum; 7LUM; -.
DR   PDBsum; 7LUP; -.
DR   PDBsum; 7NVL; -.
DR   PDBsum; 7NVM; -.
DR   PDBsum; 7NVN; -.
DR   PDBsum; 7NVO; -.
DR   PDBsum; 7TRG; -.
DR   PDBsum; 7TTN; -.
DR   PDBsum; 7TTT; -.
DR   PDBsum; 7TUB; -.
DR   PDBsum; 7WU7; -.
DR   PDBsum; 7WZ3; -.
DR   PDBsum; 7X0A; -.
DR   PDBsum; 7X0S; -.
DR   PDBsum; 7X0V; -.
DR   PDBsum; 7X3J; -.
DR   PDBsum; 7X3U; -.
DR   PDBsum; 7X6Q; -.
DR   PDBsum; 7X7Y; -.
DR   PDBsum; 8HKI; -.
DR   PDBsum; 8I1U; -.
DR   PDBsum; 8I6J; -.
DR   PDBsum; 8I9U; -.
DR   PDBsum; 8IB8; -.
DR   PDBsum; 8SFE; -.
DR   PDBsum; 8SFF; -.
DR   PDBsum; 8SG8; -.
DR   PDBsum; 8SG9; -.
DR   PDBsum; 8SGC; -.
DR   PDBsum; 8SGL; -.
DR   PDBsum; 8SGQ; -.
DR   PDBsum; 8SH9; -.
DR   PDBsum; 8SHA; -.
DR   PDBsum; 8SHD; -.
DR   PDBsum; 8SHE; -.
DR   PDBsum; 8SHF; -.
DR   PDBsum; 8SHG; -.
DR   PDBsum; 8SHL; -.
DR   PDBsum; 8SHN; -.
DR   PDBsum; 8SHO; -.
DR   PDBsum; 8SHP; -.
DR   PDBsum; 8SHQ; -.
DR   PDBsum; 8SHT; -.
DR   AlphaFoldDB; P49368; -.
DR   EMDB; EMD-0490; -.
DR   EMDB; EMD-0491; -.
DR   EMDB; EMD-0492; -.
DR   EMDB; EMD-0493; -.
DR   EMDB; EMD-0494; -.
DR   EMDB; EMD-0495; -.
DR   EMDB; EMD-12605; -.
DR   EMDB; EMD-12606; -.
DR   EMDB; EMD-12607; -.
DR   EMDB; EMD-12608; -.
DR   EMDB; EMD-13754; -.
DR   EMDB; EMD-23522; -.
DR   EMDB; EMD-23526; -.
DR   EMDB; EMD-26089; -.
DR   EMDB; EMD-26120; -.
DR   EMDB; EMD-26123; -.
DR   EMDB; EMD-26131; -.
DR   EMDB; EMD-32823; -.
DR   EMDB; EMD-32903; -.
DR   EMDB; EMD-32922; -.
DR   EMDB; EMD-32923; -.
DR   EMDB; EMD-32926; -.
DR   EMDB; EMD-32989; -.
DR   EMDB; EMD-32993; -.
DR   EMDB; EMD-33025; -.
DR   EMDB; EMD-33053; -.
DR   EMDB; EMD-34852; -.
DR   EMDB; EMD-35122; -.
DR   EMDB; EMD-35199; -.
DR   EMDB; EMD-35284; -.
DR   EMDB; EMD-35335; -.
DR   EMDB; EMD-40439; -.
DR   EMDB; EMD-40440; -.
DR   EMDB; EMD-40452; -.
DR   EMDB; EMD-40453; -.
DR   EMDB; EMD-40454; -.
DR   EMDB; EMD-40461; -.
DR   EMDB; EMD-40464; -.
DR   EMDB; EMD-40481; -.
DR   EMDB; EMD-40482; -.
DR   EMDB; EMD-40484; -.
DR   EMDB; EMD-40485; -.
DR   EMDB; EMD-40486; -.
DR   EMDB; EMD-40487; -.
DR   EMDB; EMD-40488; -.
DR   EMDB; EMD-40489; -.
DR   EMDB; EMD-40490; -.
DR   EMDB; EMD-40491; -.
DR   EMDB; EMD-40492; -.
DR   EMDB; EMD-40494; -.
DR   EMDB; EMD-4489; -.
DR   SMR; P49368; -.
DR   BioGRID; 113054; 662.
DR   ComplexPortal; CPX-6030; Chaperonin-containing T-complex.
DR   CORUM; P49368; -.
DR   DIP; DIP-32970N; -.
DR   FunCoup; P49368; 3944.
DR   IntAct; P49368; 387.
DR   MINT; P49368; -.
DR   STRING; 9606.ENSP00000295688; -.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   GlyGen; P49368; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; P49368; -.
DR   MetOSite; P49368; -.
DR   PhosphoSitePlus; P49368; -.
DR   SwissPalm; P49368; -.
DR   BioMuta; CCT3; -.
DR   DMDM; 66774185; -.
DR   OGP; P49368; -.
DR   CPTAC; CPTAC-474; -.
DR   CPTAC; CPTAC-475; -.
DR   jPOST; P49368; -.
DR   MassIVE; P49368; -.
DR   PaxDb; 9606-ENSP00000295688; -.
DR   PeptideAtlas; P49368; -.
DR   PRIDE; P49368; -.
DR   ProteomicsDB; 55998; -. [P49368-1]
DR   ProteomicsDB; 55999; -. [P49368-2]
DR   Pumba; P49368; -.
DR   TopDownProteomics; P49368-1; -. [P49368-1]
DR   Antibodypedia; 1677; 251 antibodies from 33 providers.
DR   DNASU; 7203; -.
DR   Ensembl; ENST00000295688.8; ENSP00000295688.3; ENSG00000163468.16. [P49368-1]
DR   Ensembl; ENST00000368259.6; ENSP00000357242.2; ENSG00000163468.16. [P49368-2]
DR   GeneID; 7203; -.
DR   KEGG; hsa:7203; -.
DR   MANE-Select; ENST00000295688.8; ENSP00000295688.3; NM_005998.5; NP_005989.3.
DR   UCSC; uc001fol.3; human. [P49368-1]
DR   AGR; HGNC:1616; -.
DR   ClinPGx; PA26180; -.
DR   CTD; 7203; -.
DR   DisGeNET; 7203; -.
DR   GeneCards; CCT3; -.
DR   HGNC; HGNC:1616; CCT3.
DR   HPA; ENSG00000163468; Low tissue specificity.
DR   MalaCards; CCT3; -.
DR   MIM; 600114; gene.
DR   MIM; 621034; phenotype.
DR   OpenTargets; ENSG00000163468; -.
DR   VEuPathDB; HostDB:ENSG00000163468; -.
DR   eggNOG; KOG0364; Eukaryota.
DR   GeneTree; ENSGT00570000079224; -.
DR   HOGENOM; CLU_008891_7_3_1; -.
DR   InParanoid; P49368; -.
DR   OMA; CGGSTIR; -.
DR   OrthoDB; 275057at2759; -.
DR   PAN-GO; P49368; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; P49368; -.
DR   BRENDA; 3.6.4.B10; 2681.
DR   PathwayCommons; P49368; -.
DR   Reactome; R-HSA-389957; Prefoldin mediated transfer of substrate to CCT/TriC.
DR   Reactome; R-HSA-389960; Formation of tubulin folding intermediates by CCT/TriC.
DR   Reactome; R-HSA-390450; Folding of actin by CCT/TriC.
DR   Reactome; R-HSA-390471; Association of TriC/CCT with target proteins during biosynthesis.
DR   Reactome; R-HSA-5620922; BBSome-mediated cargo-targeting to cilium.
DR   Reactome; R-HSA-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   SignaLink; P49368; -.
DR   SIGNOR; P49368; -.
DR   Agora; ENSG00000163468; -.
DR   BioGRID-ORCS; 7203; 829 hits in 1120 CRISPR screens.
DR   CD-CODE; 6F24707C; Cajal body.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; CCT3; human.
DR   GeneWiki; CCT3; -.
DR   GenomeRNAi; 7203; -.
DR   Pharos; P49368; Tbio.
DR   PRO; PR:P49368; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P49368; protein.
DR   Bgee; ENSG00000163468; Expressed in primordial germ cell in gonad and 219 other cell types or tissues.
DR   ExpressionAtlas; P49368; baseline and differential.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005832; C:chaperonin-containing T-complex; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0002199; C:zona pellucida receptor complex; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0044183; F:protein folding chaperone; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IBA:GO_Central.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl.
DR   GO; GO:1904871; P:positive regulation of protein localization to Cajal body; HMP:BHF-UCL.
DR   GO; GO:1904874; P:positive regulation of telomerase RNA localization to Cajal body; HMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; IDA:FlyBase.
DR   GO; GO:0050821; P:protein stabilization; IMP:BHF-UCL.
DR   CDD; cd03337; TCP1_gamma; 1.
DR   FunFam; 1.10.560.10:FF:000069; T-complex protein 1 subunit gamma; 1.
DR   FunFam; 1.10.560.10:FF:000076; T-complex protein 1 subunit gamma; 1.
DR   FunFam; 3.50.7.10:FF:000005; T-complex protein 1 subunit gamma; 1.
DR   Gene3D; 3.50.7.10; GroEL; 1.
DR   Gene3D; 1.10.560.10; GroEL-like equatorial domain; 1.
DR   Gene3D; 3.30.260.10; TCP-1-like chaperonin intermediate domain; 1.
DR   InterPro; IPR012719; Chap_CCT_gamma.
DR   InterPro; IPR017998; Chaperone_TCP-1.
DR   InterPro; IPR002194; Chaperonin_TCP-1_CS.
DR   InterPro; IPR002423; Cpn60/GroEL/TCP-1.
DR   InterPro; IPR027409; GroEL-like_apical_dom_sf.
DR   InterPro; IPR027413; GROEL-like_equatorial_sf.
DR   InterPro; IPR027410; TCP-1-like_intermed_sf.
DR   InterPro; IPR053374; TCP-1_chaperonin.
DR   InterPro; IPR054827; thermosome_alpha.
DR   NCBIfam; TIGR02344; chap_CCT_gamma; 1.
DR   NCBIfam; NF041082; thermosome_alpha; 1.
DR   NCBIfam; NF041083; thermosome_beta; 1.
DR   PANTHER; PTHR11353; CHAPERONIN; 1.
DR   Pfam; PF00118; Cpn60_TCP1; 1.
DR   PRINTS; PR00304; TCOMPLEXTCP1.
DR   SUPFAM; SSF52029; GroEL apical domain-like; 1.
DR   SUPFAM; SSF48592; GroEL equatorial domain-like; 1.
DR   SUPFAM; SSF54849; GroEL-intermediate domain like; 1.
DR   PROSITE; PS00750; TCP1_1; 1.
DR   PROSITE; PS00751; TCP1_2; 1.
DR   PROSITE; PS00995; TCP1_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Chaperone;
KW   Cytoplasm; Direct protein sequencing; Disease variant; Disulfide bond;
KW   Hydrolase; Intellectual disability; Isopeptide bond; Nucleotide-binding;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..545
FT                   /note="T-complex protein 1 subunit gamma"
FT                   /id="PRO_0000128321"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          526..545
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         42
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7NVO, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB"
FT   BINDING         42
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         93
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7NVO,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         94
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVO, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB,
FT                   ECO:0007744|PDB:7WZ3, ECO:0007744|PDB:7X0S"
FT   BINDING         94
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         95
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVO,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         95
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         96
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7WZ3,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         96
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         97
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7NVO, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7TUB"
FT   BINDING         162
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7X0V"
FT   BINDING         163
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVN"
FT   BINDING         411
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7NVO,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB,
FT                   ECO:0007744|PDB:7WZ3, ECO:0007744|PDB:7X0S,
FT                   ECO:0007744|PDB:7X0V"
FT   BINDING         411
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         482
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:36493755,
FT                   ECO:0000269|PubMed:37193829, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7WZ3, ECO:0007744|PDB:7X0S,
FT                   ECO:0007744|PDB:7X0V"
FT   BINDING         482
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         483
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TUB,
FT                   ECO:0007744|PDB:7WZ3"
FT   BINDING         497
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:37193829, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7WZ3,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         497
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         502
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0007744|PDB:7NVN"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|Ref.5, ECO:0007744|PubMed:19413330"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         170
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P80318"
FT   MOD_RES         222
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         247
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         430
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         459
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   DISULFID        366..372
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        15
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        248
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        249
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        381
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   VAR_SEQ         32..69
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042026"
FT   VARIANT         12
FT                   /note="Q -> R (in NEDSVH; uncertain significance; the
FT                   orthologous mutation in C. elegans results in reduced worm
FT                   motility and a crawling speed defect suggesting a
FT                   deleterious effect on function)"
FT                   /evidence="ECO:0000269|PubMed:39480921"
FT                   /id="VAR_090329"
FT   VARIANT         391
FT                   /note="L -> F (in dbSNP:rs2230194)"
FT                   /id="VAR_052265"
FT   VARIANT         518..545
FT                   /note="Missing (in NEDSVH; likely pathogenic; the
FT                   orthologous yeast mutation induces yeast lethality
FT                   suggesting loss of function)"
FT                   /evidence="ECO:0000269|PubMed:39480921"
FT                   /id="VAR_090330"
FT   CONFLICT        251
FT                   /note="E -> G (in Ref. 6; CAA52808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        345
FT                   /note="T -> A (in Ref. 8; AAC50068)"
FT                   /evidence="ECO:0000305"
FT   STRAND          10..13
FT                   /evidence="ECO:0007829|PDB:7TTT"
FT   STRAND          15..17
FT                   /evidence="ECO:0007829|PDB:8SH9"
FT   HELIX           20..37
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           38..40
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:8I9U"
FT   STRAND          47..51
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:8I9U"
FT   STRAND          57..60
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           63..69
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           75..90
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          92..94
FT                   /evidence="ECO:0007829|PDB:7X0A"
FT   HELIX           97..114
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           119..140
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           149..160
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:7TTT"
FT   HELIX           164..168
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           169..183
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          184..189
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          191..193
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            195..197
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          198..207
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           209..211
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          213..217
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          219..221
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          224..226
FT                   /evidence="ECO:0007829|PDB:8SHT"
FT   STRAND          231..235
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          238..243
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          250..253
FT                   /evidence="ECO:0007829|PDB:8I9U"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:8SH9"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:7TRG"
FT   HELIX           263..283
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          288..294
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           298..306
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          310..312
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           317..327
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:7TTT"
FT   HELIX           335..337
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           340..342
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          350..355
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          358..362
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          366..368
FT                   /evidence="ECO:0007829|PDB:8SGC"
FT   STRAND          372..379
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           381..403
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          407..409
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            410..412
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           413..426
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           434..443
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           446..455
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           459..469
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          472..474
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          478..480
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            482..484
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          487..489
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           490..493
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          496..498
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           499..518
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          519..524
FT                   /evidence="ECO:0007829|PDB:7NVL"
SQ   SEQUENCE   545 AA;  60534 MW;  0A528762EF24F36B CRC64;
     MMGHRPVLVL SQNTKRESGR KVQSGNINAA KTIADIIRTC LGPKSMMKML LDPMGGIVMT
     NDGNAILREI QVQHPAAKSM IEISRTQDEE VGDGTTSVII LAGEMLSVAE HFLEQQMHPT
     VVISAYRKAL DDMISTLKKI SIPVDISDSD MMLNIINSSI TTKAISRWSS LACNIALDAV
     KMVQFEENGR KEIDIKKYAR VEKIPGGIIE DSCVLRGVMI NKDVTHPRMR RYIKNPRIVL
     LDSSLEYKKG ESQTDIEITR EEDFTRILQM EEEYIQQLCE DIIQLKPDVV ITEKGISDLA
     QHYLMRANIT AIRRVRKTDN NRIARACGAR IVSRPEELRE DDVGTGAGLL EIKKIGDEYF
     TFITDCKDPK ACTILLRGAS KEILSEVERN LQDAMQVCRN VLLDPQLVPG GGASEMAVAH
     ALTEKSKAMT GVEQWPYRAV AQALEVIPRT LIQNCGASTI RLLTSLRAKH TQENCETWGV
     NGETGTLVDM KELGIWEPLA VKLQTYKTAV ETAVLLLRID DIVSGHKKKG DDQSRQGGAP
     DAGQE
//
